BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36627111)

  • 21. Treatment of Kaposi sarcoma in children with HIV-1 infection.
    Anglemyer A; Agrawal AK; Rutherford GW
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
    Ziegler JL; Katongole-Mbidde E
    Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa.
    Freeman EE; Semeere A; McMahon DE; Byakwaga H; Laker-Oketta M; Regan S; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Wools-Kaloustian K; Bassett IV; Busakhala N; Martin J
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1119-1127. PubMed ID: 33871409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated Kaposi sarcoma in African children.
    Feller L; Khammissa RA; Gugushe TS; Chikte UM; Wood NH; Meyerov R; Lemmer J
    SADJ; 2010 Feb; 65(1):20-2. PubMed ID: 20411798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.
    Nyirenda M; Ngongondo M; Kang M; Umbleja T; Krown SE; Godfrey C; Samaneka W; Mngqibisa R; Hoagland B; Mwelase N; Caruso S; Martinez-Maza O; Dittmer DP; Borok M; Hosseinipour MC; Campbell TB;
    J Acquir Immune Defic Syndr; 2020 Aug; 84(4):422-429. PubMed ID: 32265361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
    Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
    Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
    Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M
    J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
    Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
    PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
    Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
    BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.
    Openshaw MR; Gervasi E; Fulgenzi CAM; Pinato DJ; Dalla Pria A; Bower M
    J Transl Med; 2023 Apr; 21(1):283. PubMed ID: 37106396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographic and immune correlates of human herpesvirus 8 seropositivity in Malawi, Africa.
    DeSantis SM; Pau CP; Archibald LK; Nwanyanwu OC; Kazembe PN; Dobbie H; Jarvis WR; Jason J
    Int J Infect Dis; 2002 Dec; 6(4):266-71. PubMed ID: 12718819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
    Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
    Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
    Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe Kaposi Sarcoma in an Urban Public Hospital.
    Kasturia SE; Gunthel C; Zeng C; Nguyen ML
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):583-589. PubMed ID: 28019110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.